510(k) device
MicroPlex Coil System (MCS) - HyperSoft 3D
MicroVention, Inc. · Device, Neurovascular Embolization (HCG, Class II) · First FDA decision Oct 29, 2001, newest Aug 31, 2016Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
12
510(k) pathway
Device trials
0
Naming "MicroPlex Coil"
MAUDE reports
3
Brand "MicroPlex Coil", since 2015
PubMed studies
0
Mentioning "MicroPlex Coil"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MicroPlex Coil System (MCS) - HyperSoft 3D
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 12 decisions filed under this name.
K161452 · Decided Aug 31, 2016 · 97 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
5 more FDA decisions with a free account
Older decisions: K050954, K032590, K022735, K021914, K020434, K012145
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MicroPlex Coil", any status and sponsor, newest update first.
No registered device study names "MicroPlex Coil".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MicroPlex Coil", and for the whole product code for context.
This brand
3 reports: 2 malfunction, 1 injury, 0 death
Whole product code HCG
16,697 reports: 13,955 malfunction, 2,524 injury, 162 death
Newest reports for this brand
MW5116751 · Received Apr 17, 2023 · Event dated Apr 10, 2023
Device type: Device, Neurovascular Embolization (HCG)
Device problem as coded: Separation Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1392-2020 · Started Nov 22, 2019
Reason given: The devices may be missing the implant coil.
Cause as FDA categorized it: Process design · Device type: Device, Neurovascular Embolization (HCG)
15 more recall records with a free account
Published research
The most relevant PubMed records for "MicroPlex Coil"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HCG.
- Micrus Microcoil Delivery SystemMicrus Endovascular Corporation · 510(k) 2008
- HydroCoil Embolic System (HES)MicroVention, Inc. · 510(k) 2016
- Barricade Embolization Coil SystemBlockade Medical · 510(k) 2015
- Optima Coil System (OptiOne Coil System)Balt USA, LLC · 510(k) 2026
- Target Detachable CoilStryker Neurovascular · 510(k) 2025
- Trufill Dcs Orbit Detachable Coil and Trufill Dcs Syringe or Trufill Dcs Syringe IICordis Neurovascular, Inc. · 510(k) 2008
- Nexus Detachable Coil System, Morpheus 3D CsrMicro Therapeutics, Inc. · 510(k) 2006
- Numen Coil Embolization SystemMicroPort NeuroTech (Shanghai) Co., Ltd. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.